{
  "meta": {
    "title": "Porphyria",
    "url": "https://brainandscalpel.vercel.app/porphyria-fb3c97a2.html",
    "scrapedAt": "2025-11-29T18:23:55.927Z"
  },
  "questions": [
    {
      "id": 7684,
      "choices": [
        {
          "id": 30704,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute intermittent porphyria</span></span></span></p>"
        },
        {
          "id": 30705,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></span></span></p>"
        },
        {
          "id": 30706,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria</span></span></span></p>"
        },
        {
          "id": 30707,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male presents to the clinic with a history of skin fragility and blistering on sun-exposed areas. He also reports significant liver disease history and excessive alcohol consumption. Laboratory tests show elevated porphyrins in urine. The patient&#39;s symptoms and laboratory findings suggest a diagnosis related to porphyrin metabolism. Which of the following types of porphyria is characterized by a deficiency in the enzyme uroporphyrinogen decarboxylase?</span></span></span></p>",
      "unique_key": "Q1829943",
      "question_audio": null,
      "question_video": null,
      "map_id": 30193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> disease</strong> is due to <strong>deficiency of uroporphyrinogen decarboxylase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Precipitating factors</strong> -<strong>Hepatic injury </strong>caused by environmental (<strong>ethanol</strong>) and <strong>infectious</strong> (<strong>hepatitis B virus</strong>) agents and <strong>exposure to sunlight.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyrin</strong> accumulates in<strong> circulation</strong> leads to <strong>cutaneous symptoms</strong> and gets <strong>excreted in urine</strong>, turning it <strong>red to brown. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: A</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">cute intermittent porphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Uroporphyrinogen I synthase</strong>; C/F-<strong>Abdominal pain, neuropsychiatric</strong> <strong>symptoms</strong> with <strong>increased urinary ALA and PBG.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: C</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ongenital erythropoietic porphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Uroporphyrinogen III synthase</strong>; C/F- <strong>Photosensitivity with increased</strong> u<strong>roporphyrin I</strong> in<strong> urinary, faecal, and red cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of <strong>Coproporphyrinogen oxidase</strong>; C/F<strong>-Photosensitivity, abdominal pain,</strong> <strong>neuropsychiatric symptoms</strong> with<strong> urinary ALA, PBG</strong>, and <strong>coproporphyrin III </strong>and <strong>faecal coproporphyrin III increased.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyria cutanea tarda (PCT) </strong>is the most common form of<strong> porphyria </strong>and is characterized by a<strong> deficiency of the enzyme</strong> <strong>uroporphyrinogen decarboxylase (UROD). </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 274.</span></span></strong></p>",
      "correct_choice_id": 30705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7679,
      "choices": [
        {
          "id": 30684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A </span></span></span></p>"
        },
        {
          "id": 30685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong </span></span></span></p>"
        },
        {
          "id": 30686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement </span></span></span></p>"
        },
        {
          "id": 30687,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> AIP (acute intermittent porphyria) has abdominal pain and neuropsychiatric features as common presentation.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:</strong> The above symptoms are due to accumulation of ALA and PBG. ALA inhibits ATPase in the nervous system leads to conduction paralysis. </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate interpretation of the Assertion and Reasoning provided?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q3736369",
      "question_audio": null,
      "question_video": null,
      "map_id": 30197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right, and R is a correct explanation of A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defective enzyme</strong> in <strong>acute intermittent porphyria</strong> is <strong>hydroxymethylbilane synthase (uroporphyrinogen I synthase</strong>),</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ALA </strong>and <strong>porphobilinogen </strong>accumulate in <strong>body tissues and fluids</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F: <strong>Abdominal and neurological manifestations</strong> like <strong>sensory and motor disturbances, confusion, agitation and</strong> <strong>psychiatric problems.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No photosensitivity</span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture8.jpg\" style=\"height:490px; width:700px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acute Intermittent Porphyria (AIP) </strong>is marked by a <strong>lack of porphobilinogen deaminase</strong>, causing <strong>delta-aminolevulinic acid </strong>and <strong>porphobilinogen buildup</strong>, leading to<strong> abdominal pain and neuropsychiatric symptoms</strong>. This is <strong>due to ALA&#39;s neurotoxicity, </strong>which <strong>inhibits ATPase in neurons,</strong> resulting in <strong>neuronal dysfunction and paralysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 328-329</span></strong></span></span></p>",
      "correct_choice_id": 30687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7681,
      "choices": [
        {
          "id": 30692,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen Synthase</span></span></p>"
        },
        {
          "id": 30693,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen III Synthase</span></span></p>"
        },
        {
          "id": 30694,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen Decarboxylase</span></span></p>"
        },
        {
          "id": 30695,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coproporphyrinogen Oxidase</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy presents to the pediatric clinic with a notably disfigured face, pronounced photosensitivity, stained teeth, and laboratory tests revealing elevated levels of Coproporphyrin-I. Based on these clinical findings, which enzyme deficiency is most likely responsible for this patient&#39;s condition?</span></span></span></p>",
      "unique_key": "Q3101063",
      "question_audio": null,
      "question_video": null,
      "map_id": 30192,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uroporphyrinogen III Synthase</span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital erythropoietic porphyria </strong>has <strong>AR inheritance </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The defective enzyme - <strong>uroporphyrinogen III synthase </strong>leads to <strong>increase</strong> in levels of <strong>porphyrin I</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Their <strong>excretion in urine</strong> makes the <strong>urine dark red </strong>in colour (port wine appearance)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reactive oxygen species</strong> are the cause for attacks of <strong>dermatitis </strong>and scarring which leads to <strong>severe disfigurement</strong> referred to as <strong>&lsquo;monkey face</strong>&rsquo;. Also<strong> photosensitivity</strong> is reported.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When<strong> UV light </strong>is reflected <strong>onto teeth a red fluorescence </strong>is seen; this is called <strong>erythrodontia. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uroporphyrinogen Synthase</strong> - A <strong>deficiency</strong> in this enzyme would <strong>not</strong> lead to the specific accumulation of <strong>Coproporphyrin-I</strong>, nor would it directly result in the<strong> clinical syndrome</strong> described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uroporphyrinogen Decarboxylase</strong> - <strong>Deficiency</strong> in this enzyme leads to <strong>Porphyria Cutanea Tarda (PCT)</strong>, the <strong>most common</strong> type of <strong>porphyria,</strong> which presents with<strong> skin fragility and blistering on sun-exposed areas, </strong>but <strong>not</strong> the <strong>severe disfigurement </strong>or <strong>erythrodontia </strong>seen in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coproporphyrinogen Oxidase</strong> - <strong>Deficiency </strong>of this enzyme results in <strong>Hereditary Coproporphyria, </strong>which can cause <strong>photosensitivity and neurological symptoms </strong>but<strong> does not </strong>typically present with the <strong>severe facial disfigurement </strong>or <strong>stained teeth </strong>as described in the patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital Erythropoietic Porphyria (CEP),</strong> a <strong>rare disorder </strong>caused by a <strong>deficiency in Uroporphyrinogen III Synthase.</strong> The accumulation of <strong>specific porphyrins </strong>leads to symptoms including <strong>photosensitivity, facial disfigurement, and stained teeth,</strong> <strong>emphasizing </strong>the critical role of the<strong> heme biosynthesis pathway</strong> in maintaining <strong>normal physiological functions</strong> and the <strong>diverse</strong> <strong>clinical manifestations</strong> that can<strong> arise</strong> from <strong>its disruption.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 327-329</span></span></strong></p>",
      "correct_choice_id": 30693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7688,
      "choices": [
        {
          "id": 30720,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute intermittent porphyria </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"> </span></span></span></p>"
        },
        {
          "id": 30721,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria </span></span></span></p>"
        },
        {
          "id": 30722,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythropoietic protoporphyria </span></span></span></p>"
        },
        {
          "id": 30723,
          "text": "<p style=\"margin-left:6px\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">55-year-old male, who works as a golf instructor, presents to the clinic with sudden onset of painful blisters on the backs of his hands. He reports no recent exposure to skin irritants. His medical history is significant for complex partial seizures following a head injury, for which he has been taking phenytoin. He admits to consuming alcohol on a weekly basis. Laboratory tests reveal reddish-orange urine with elevated levels of uroporphyrin. Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture13.jpg\" style=\"height:193px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1169142",
      "question_audio": null,
      "question_video": null,
      "map_id": 30194,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The disease is due to <strong>deficiency of uroporphyrinogen decarboxylase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Precipitating factors</strong> - <strong>Hepatic injury</strong> caused by environmental (<strong>ethanol</strong>) and infectious (<strong>hepatitis B virus</strong>) agents and <strong>exposure to sunlight.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyrin </strong>accumulates in circulation leads to<strong> cutaneous symptoms and gets excreted in urine</strong>, turns it <strong>red to brown. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of this<strong> patient&rsquo;s seizure disorder</strong> with <strong>phenytoin</strong> </span><span style=\"font-family:Wingdings\">&rarr;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> increased synthesis </strong>of<strong> d-amino levulinic acid synthase </strong></span><span style=\"font-family:Wingdings\">&rarr;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>increased uroporphyrinogen</strong>, on which the<strong> deficient enzyme acts.</strong> The <strong>laboratory and clinical findings </strong>are<strong> not</strong> seen in other <strong>porphyria&rsquo;s.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acute intermittent porphyria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency of Uroporphyrinogen I synthase;</strong> C/F-<strong>Abdominal pain, neuropsychiatric</strong> <strong>symptoms</strong> with<strong> increased urinary ALA and PBG.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Congenital erythropoietic porphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of Uroporphyrinogen III synthase;</strong> C/F-<strong> Photosensitivity </strong>with <strong>increased</strong> <strong>uroporphyrin I in urinary, fecal, and red cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hereditary coproporphyria: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of Coproporphyrinogen oxidase;</strong> C/F-<strong>Photosensitivity, abdominal pain,</strong> <strong>neuropsychiatric symptoms</strong> with <strong>urinary ALA, PBG, and coproporphyrin III </strong>and <strong>faecal coproporphyrin III increased.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Porphyria cutanea tarda (PCT)</strong> is the most common form of<strong> porphyria </strong>and is characterized by <strong>photosensitivity </strong>leading to<strong> skin</strong> <strong>fragility and blistering</strong> on <strong>sun-exposed areas</strong>, such as the <strong>backs of the hands</strong>. Factors that can <strong>precipitate PCT </strong>include <strong>alcohol</strong> <strong>consumption, liver disease, and estrogen use</strong>. Additionally, certain medications, such as <strong>phenytoin,</strong> can exacerbate the condition. The <strong>elevated levels of uroporphyrin </strong>in the <strong>urine, </strong>along with the<strong> clinical presentation and history,</strong> are<strong> indicative of PCT.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 6/e: p 280.</span></span></strong></p>",
      "correct_choice_id": 30723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7694,
      "choices": [
        {
          "id": 30744,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute intermittent porphyria</span></span></span></p>"
        },
        {
          "id": 30745,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria</span></span></span></p>"
        },
        {
          "id": 30746,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda</span></span></span></p>"
        },
        {
          "id": 30747,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most likely diagnosis based on the image given below:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture17.jpg\" style=\"height:201px; width:300px\" /></span></span></p>",
      "unique_key": "Q3880687",
      "question_audio": null,
      "question_video": null,
      "map_id": 30195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital erythropoietic porphyria</span></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital erythropoietic porphyria </strong>has <strong>AR inheritance </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The defective enzyme &ndash; <strong>uroporphyrinogen III synthase </strong>leads to <strong>increase in levels of porphyrin I</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Their excretion in urine makes the <strong>urine dark red in colour (port wine appearance)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reactive oxygen species are the cause for attacks of <strong>dermatitis </strong>and scarring which leads to <strong>severe disfigurement</strong> referred to as &lsquo;<strong>monkey face</strong>&rsquo;. Also <strong>photosensitivity</strong> is reported.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>UV light </strong>is reflected onto <strong>teeth a red fluorescence </strong>is seen; this is called <strong>erythrodontia. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute intermittent porphyria (AIP):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Deficiency of Uroporphyrinogen I synthase;</strong> C/F-<strong>Abdominal pain, neuropsychiatric</strong> <strong>symptoms</strong> with <strong>increased urinary ALA and PBG.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Porphyria cutanea tarda:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency of uroporphyrinogen decarboxylase. Porphyrin</strong> accumulates in circulation leads to <strong>cutaneous symptoms</strong> and gets <strong>excreted in urine,</strong> turns it <strong>red to brown. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary coproporphyria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency of Coproporphyrinogen oxidase</strong>; C/F-<strong>Photosensitivity, abdominal pain,</strong> <strong>neuropsychiatric symptoms</strong> with <strong>urinary ALA, PBG, and coproporphyrin III </strong>and<strong> faecal coproporphyrin III increased.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Congenital erythropoietic porphyria (CEP), </strong>also known as <strong>G&uuml;nther&#39;s disease</strong>, is a <strong>rare autosomal recessive disorder</strong> characterized by the <strong>defective synthesis of heme</strong>, leading to the <strong>accumulation of porphyrins</strong> in various tissues, including the<strong> bones and teeth</strong>. The clinical findings of <strong>reddish-brown discoloration of teeth </strong>(<strong>erythrodontia</strong>) that<strong> fluoresce under UV light</strong>, and <strong>red urine</strong> that may <strong>darken </strong>upon <strong>exposure to light, </strong>are <strong>pathognomonic </strong>for <strong>CEP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 327-329.</span></span></strong></p>",
      "correct_choice_id": 30745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7696,
      "choices": [
        {
          "id": 30752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen synthesis</span></span></span></p>"
        },
        {
          "id": 30753,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></span></span></p>"
        },
        {
          "id": 30754,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA repair</span></span></span></p>"
        },
        {
          "id": 30755,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heme synthesis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy presents with mild anemia, photosensitivity, and skin blistering. His symptoms exacerbated while on rifampin treatment for a methicillin-resistant Staphylococcus aureus (MRSA) infection. Considering his clinical presentation, which biochemical pathway is most likely impaired in this boy?</span></span></span></p>",
      "unique_key": "Q8374822",
      "question_audio": null,
      "question_video": null,
      "map_id": 30196,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heme synthesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The boy has <strong>porphyria</strong>, a<strong> reduced </strong>ability to <strong>synthesize heme. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>super sensitivity</strong> to the<strong> sun</strong> is <strong>due</strong> to the <strong>presence of heme precursors in skin cells</strong> that are easily converted to <strong>radial form by the energy in sunlight </strong>and which <strong>severely damage</strong> the<strong> cell. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>drug boy</strong> is taking is <strong>metabolized via a cytochrome P450 system</strong>, which is induced when the <strong>drug first enters </strong>the <strong>circulation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Induction of P450 systems </strong>induced the <strong>synthesis of heme leading</strong> to <strong>increased concentrations </strong>of the<strong> heme</strong> intermediates and an <strong>increased sensitivity</strong> to the effects of these <strong>intermediates </strong>as induced by<strong> sunlight. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>anemia</strong> is due to<strong> reduced heme levels</strong> in the<strong> red blood cells. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen synthesis: Defects </strong>in <strong>glycogen synthesis</strong> or <strong>its metabolism</strong> usually present with <strong>muscle cramps, exercise</strong> <strong>intolerance, or hypoglycemia</strong>, not photosensitivity or skin blistering.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid oxidation:</strong> <strong>Disorders in fatty acid oxidation</strong> typically manifest with<strong> hypoketotic hypoglycemia, hepatomegaly,</strong> or <strong>muscle weakness, not</strong> the symptoms described in the vignette.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>DNA repair:</strong> While <strong>defects in DNA repair </strong>mechanisms can lead to<strong> photosensitivity </strong>(e.g., <strong>xeroderma pigmentosum</strong>), they would<strong> not </strong>explain the <strong>anemia </strong>or the<strong> worsening of symptoms</strong> with<strong> rifampin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clinical manifestations</strong> of disorders of <strong>heme synthesis</strong>, such as <strong>porphyrias</strong>, which can present with <strong>photosensitivity</strong>, <strong>skin</strong> <strong>blistering, and anemia. </strong>It is also <strong>important</strong> to recognize that <strong>certain medications, </strong>like<strong> rifampin,</strong> can<strong> exacerbate</strong> these conditions by <strong>inducing hepatic enzymes</strong> and thus<strong> increasing the demand for heme synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 271.</span></span></strong></p>",
      "correct_choice_id": 30755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}